Which of the following statements about obesity is NOT true? A) Bariatric surgery usually treats patients with severe obesity (body mass index >40) B) Severe obesity increases cancer risk by 50% C) Less than 1% of obese individuals succeed in losing 10% of their body weight for greater than or equal to 1 year D) Physician training in obesity management needs improvement E) Bariatric surgery can have complications.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

The FALSE Statement is C

Statement C is NOT true: Less than 1% of obese individuals succeed in losing 10% of their body weight for ≥ 1 year is an overly pessimistic claim that contradicts current evidence. 1

Analysis of Each Statement

Statement A: TRUE - Bariatric Surgery for Severe Obesity (BMI >40)

The 1991 NIH guidelines, still widely used today, recommend bariatric surgery for patients with BMI ≥40 or BMI ≥35 with serious obesity-related comorbidities 2. Modern practice has expanded indications to include patients with type 2 diabetes and BMI 30-35 when hyperglycemia is inadequately controlled 2. This statement accurately reflects standard practice.

Statement B: TRUE - Severe Obesity Increases Cancer Risk by 50%

Obesity is associated with increased cancer risk across multiple malignancies (endometrial, esophageal, gastric, kidney, colorectal, liver, gallbladder, pancreas, prostate, postmenopausal breast, ovarian, and thyroid cancers) 3. Overweight and obesity account for approximately 10% of new cancer diagnoses annually in the US and up to 50% of certain cancers such as endometrial and hepatobiliary cancer 3. This statement is accurate for specific cancer types.

Statement C: FALSE - Weight Loss Success Rates

The 2023 JAMA guideline explicitly contradicts this pessimistic claim. Behavioral interventions can achieve approximately 5% to 10% weight loss, with weight regain occurring in 25% or more of participants at 2-year follow-up 1. This means that approximately 75% maintain their weight loss at 2 years—far exceeding the "less than 1%" claim. Additionally, modern pharmacotherapy (GLP-1 agonists achieving 8-21% weight loss) and bariatric surgery (achieving 25-30% weight loss) provide even better outcomes 1.

Statement D: TRUE - Physician Training Needs Improvement

Medical professional barriers include failing to recognize causes of obesity, providing recommendations inconsistent with current obesity treatment guidelines, and being uncomfortable counseling patients about treatment options for severe obesity 4. This represents a well-documented gap in medical education and practice.

Statement E: TRUE - Bariatric Surgery Has Complications

Bariatric surgery carries perioperative mortality rates of 0.03% to 0.2% 2. Surgically treated patients have a greater risk for undergoing at least 1 additional gastrointestinal surgical procedure (31.3% vs 15.5% in medical treatment) 5. The proportion of patients with low ferritin levels is significantly greater in surgical groups (26% vs 12%) 5. Long-term nutritional deficiencies include iron, folate, vitamin B12, vitamin D, and calcium 6. These complications are real and well-documented.

Clinical Implications

The false statement (C) perpetuates therapeutic nihilism about obesity treatment. Current evidence demonstrates that:

  • Behavioral interventions alone achieve meaningful weight loss in the majority of patients at 2 years 1
  • Modern pharmacotherapy dramatically improves outcomes beyond lifestyle interventions 1
  • Bariatric surgery achieves 25-30% weight loss at 12 months 1

The outdated "less than 1%" statistic undermines patient motivation and physician willingness to offer evidence-based obesity treatments, contributing to the treatment gap where less than 1% of appropriate candidates actually receive bariatric surgery annually 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.